156 related articles for article (PubMed ID: 36891719)
1. [Guideline for the prevention and treatment of hepatitis C (2022 version)].
;
Zhonghua Gan Zang Bing Za Zhi; 2022 Dec; 30(12):1332-1348. PubMed ID: 36891719
[TBL] [Abstract][Full Text] [Related]
2. [Guidelines for the prevention and treatment of hepatitis C (2019 version)].
;
Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):962-979. PubMed ID: 31941258
[TBL] [Abstract][Full Text] [Related]
3. [Highlights of the guidelines of prevention and treatment for hepatitis C (2019 version)].
Rao HY; Duan ZP; Wang GQ; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2020 Feb; 28(2):129-132. PubMed ID: 32164062
[TBL] [Abstract][Full Text] [Related]
4. [Guidelines for the prevention and treatment of chronic hepatitis B (version 2022)].
;
Zhonghua Gan Zang Bing Za Zhi; 2022 Dec; 30(12):1309-1331. PubMed ID: 36891718
[TBL] [Abstract][Full Text] [Related]
5. [Interpretation of the important update of the Guideline for the prevention and treatment of hepatitis C (2022 edition)].
Rao HY; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2023 Jul; 31(7):688-691. PubMed ID: 37580249
[TBL] [Abstract][Full Text] [Related]
6. [Progress, challenges and countermeasures of global hepatitis C elimination].
Chen ZD
Zhonghua Gan Zang Bing Za Zhi; 2020 Oct; 28(10):812-816. PubMed ID: 33105922
[TBL] [Abstract][Full Text] [Related]
7. [Research progress on clinical antiviral treatment of chronic hepatitis B in children].
; ; ;
Zhonghua Gan Zang Bing Za Zhi; 2024 May; 32(5):435-448. PubMed ID: 38858193
[TBL] [Abstract][Full Text] [Related]
8. KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C.
Roth D; Bloom RD; Molnar MZ; Reese PP; Sawinski D; Sise ME; Terrault NA
Am J Kidney Dis; 2020 May; 75(5):665-683. PubMed ID: 32279907
[TBL] [Abstract][Full Text] [Related]
9. Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization's global health sector strategy core indicators and scaling up key interventions.
Duffell EF; Hedrich D; Mardh O; Mozalevskis A
Euro Surveill; 2017 Mar; 22(9):. PubMed ID: 28277217
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.
AASLD-IDSA HCV Guidance Panel
Clin Infect Dis; 2018 Oct; 67(10):1477-1492. PubMed ID: 30215672
[TBL] [Abstract][Full Text] [Related]
11. Can hepatitis C be eradicated in the United States?
Edlin BR; Winkelstein ER
Antiviral Res; 2014 Oct; 110():79-93. PubMed ID: 25110202
[TBL] [Abstract][Full Text] [Related]
12. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
13. [Price analyses on direct-acting antiviral drugs of hepatitis C].
Duan CAX; Sui BY; Chen ZD; Zhao K
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct; 54(10):1161-1164. PubMed ID: 33115205
[TBL] [Abstract][Full Text] [Related]
14. Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020.
Scott N; Ólafsson S; Gottfreðsson M; Tyrfingsson T; Rúnarsdóttir V; Hansdottir I; Hernandez UB; Sigmundsdóttir G; Hellard M
J Hepatol; 2018 May; 68(5):932-939. PubMed ID: 29274408
[TBL] [Abstract][Full Text] [Related]
15. [The guidelines of prevention and treatment for chronic hepatitis B (2019 version)].
;
Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):938-961. PubMed ID: 31941257
[TBL] [Abstract][Full Text] [Related]
16. [From treatable to curable to eliminated ---- a decade of research progress in the diagnosis and treatment of hepatitis C].
Rao HY; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):102-107. PubMed ID: 33685075
[TBL] [Abstract][Full Text] [Related]
17. Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022).
You H; Wang F; Li T; Xu X; Sun Y; Nan Y; Wang G; Hou J; Duan Z; Wei L; Jia J; Zhuang H;
J Clin Transl Hepatol; 2023 Nov; 11(6):1425-1442. PubMed ID: 37719965
[TBL] [Abstract][Full Text] [Related]
18. [In-hospital process for viral hepatitis C screening and management in China (Draft)].
; ; ;
Zhonghua Gan Zang Bing Za Zhi; 2021 Apr; 29(4):319-325. PubMed ID: 33979957
[TBL] [Abstract][Full Text] [Related]
19. On a straight path to HCV elimination in children - new prospects for hepatitis C treatment in Poland.
Pluta M; Pokorska-Śpiewak M; Aniszewska M; Marczyńska M
Przegl Epidemiol; 2020; 74(4):662-666. PubMed ID: 33861033
[TBL] [Abstract][Full Text] [Related]
20. Cascade of care during the first 36 months of the treatment as prevention for hepatitis C (TraP HepC) programme in Iceland: a population-based study.
Olafsson S; Fridriksdottir RH; Love TJ; Tyrfingsson T; Runarsdottir V; Hansdottir I; Bergmann OM; Björnsson ES; Johannsson B; Sigurdardottir B; Löve A; Baldvinsdottir GE; Hernandez UB; Gudnason T; Heimisdottir M; Hellard M; Gottfredsson M
Lancet Gastroenterol Hepatol; 2021 Aug; 6(8):628-637. PubMed ID: 34171267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
